RESUMEN
BACKGROUND: Consequences of the volume outcome relationship are controversial. Objectification based on data analysis is strongly needed. The aim of this publication was to analyse the effects of volume outcome reallocations based on German inpatient data. METHOD: The analysis based on inpatient data of the Krankenhauszweckverband Koeln, Bonn und Region (Hospital Association of the Cologne and Bonn Region) of 2002 and 2005. Relevant data sets were identified according to the effects of current German regulations on volume outcome on the special fields liver transplant, kidney transplant, complex pancreatic surgery, and complex oesophageal surgery. RESULTS: The effects of current German regulations on volume outcome results differed greatly between the four surgical specialities. There were fewer effects on kidney transplant, but due to an already very high level of centralisation 34% (oesophagus) and 8% (pancreas) of the hospitals stopped related surgery. This affected 8.9% (oesophagus) and 2.2% (pancreas) of related cases. CONCLUSION: Concentration and the formation of specialised medical centres are results of the implementation of volume outcome relationships. The quality of medical treatment does not automatically improve from this development. It is necessary to analyse any correlation between quality and frequency of treatment or other criteria such as know-how, structure and process management, and multidisciplinarity.
Asunto(s)
Competencia Clínica/legislación & jurisprudencia , Competencia Clínica/normas , Programas Nacionales de Salud/legislación & jurisprudencia , Garantía de la Calidad de Atención de Salud/legislación & jurisprudencia , Garantía de la Calidad de Atención de Salud/normas , Procedimientos Quirúrgicos Operativos/legislación & jurisprudencia , Procedimientos Quirúrgicos Operativos/normas , Benchmarking/legislación & jurisprudencia , Benchmarking/normas , Competencia Clínica/estadística & datos numéricos , Enfermedades del Esófago/mortalidad , Enfermedades del Esófago/cirugía , Alemania , Humanos , Trasplante de Riñón/legislación & jurisprudencia , Trasplante de Riñón/mortalidad , Trasplante de Riñón/normas , Trasplante de Riñón/estadística & datos numéricos , Trasplante de Hígado/legislación & jurisprudencia , Trasplante de Hígado/mortalidad , Trasplante de Hígado/normas , Trasplante de Hígado/estadística & datos numéricos , Evaluación de Resultado en la Atención de Salud/legislación & jurisprudencia , Evaluación de Resultado en la Atención de Salud/estadística & datos numéricos , Enfermedades Pancreáticas/mortalidad , Enfermedades Pancreáticas/cirugía , Garantía de la Calidad de Atención de Salud/estadística & datos numéricos , Especialización/legislación & jurisprudencia , Especialización/estadística & datos numéricos , Especialización/tendencias , Procedimientos Quirúrgicos Operativos/mortalidad , Procedimientos Quirúrgicos Operativos/estadística & datos numéricos , Análisis de Supervivencia , Revisión de Utilización de Recursos/estadística & datos numéricosRESUMEN
The switching behavior of submicron circular Permalloy nanomagnets has been investigated. Electron holography provides a magnetic resolution of down to 10 nm. This allows us to observe in detail the switching and to measure the induction within single nanodots with diameters down to 150 nm at a thickness of 6 nm. Particles of these dimensions show a single domain state during the whole switching process which takes place at external fields of only a few 100 A/m. For larger or thicker particles the magnetization reversal runs via the formation of a C state or an intermediate vortex state.
RESUMEN
In order to improve the quality of medical care, minimum volumes for services were set. Hospitals are only permitted to continue to provide these services and settle accounts with the health insurance companies if they are able to achieve these minimum annual volumes. This study is based on service data of the year 2002 from 88 neighboring hospitals of the hospital association Cologne, Bonn and region. In the study, the influence of these regulations on the provision of health care services in cardiology were examined. The cases were grouped according to the different examined services, followed by an analysis of the number of cases for each hospital in comparison to four fictitious minimum quantity models. When the hospital's volume remained below the minimum quantity, these cases were assigned to the nearest hospital still able to provide the service. For the services coronary angiography, PTCA, AICD implantation, EPS and ablation, only marginal case redistributions were determined. Depending on the minimum quantity, service concentrations are only expected for pacemaker implantations. Due to the increasing service concentration as a consequence of the DRG-payment system, a bureaucratic regulation of minimum volumes has become superfluous for most cardiological services. Instead of minimum volume regulations, recommendation of minimum volumes should be made in cardiological guidelines.
Asunto(s)
Servicio de Cardiología en Hospital/estadística & datos numéricos , Atención a la Salud/legislación & jurisprudencia , Programas Nacionales de Salud/legislación & jurisprudencia , Garantía de la Calidad de Atención de Salud/legislación & jurisprudencia , Servicio de Cardiología en Hospital/legislación & jurisprudencia , Recolección de Datos/estadística & datos numéricos , Grupos Diagnósticos Relacionados/legislación & jurisprudencia , Alemania , Guías como Asunto , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Sistemas de Información en Hospital/estadística & datos numéricos , Servicios Hospitalarios Compartidos/legislación & jurisprudencia , Servicios Hospitalarios Compartidos/estadística & datos numéricos , Humanos , Transferencia de Pacientes/legislación & jurisprudencia , Revisión de Utilización de Recursos/legislación & jurisprudenciaRESUMEN
OBJECTIVE: To explore the neurochemical basis of REM sleep behavior disorder (RBD) in multiple-system atrophy (MSA). METHODS: In 13 patients with probable MSA, nocturnal, laboratory-based polysomnography was used to rate the severity of REM atonia loss by the percentage of REM sleep with tonically increased electromyographic (EMG) activity and the percentage of REM sleep with phasic EMG bursts. PET with (+)-[11C]dihydrotetrabenazine ([11C]DTBZ) was employed to measure the density of striatal monoaminergic terminals and SPECT with (-)-5-[123I]iodobenzovesamicol ([123I]IBVM) to measure the density of 123I]IBVM. RESULTS: Age and gender distributions were similar in patient and normal control groups. The MSA subjects showed decreased mean [11C]DTBZ binding in the striatum (p < 0.0001) and decreased [123I]IBVM binding in the thalamus (p < 0.001). Moreover, in the MSA group, striatal [11C]DTBZ binding was inversely correlated with the severity of REM atonia loss (p = 0.003). Thalamic [123I]IBVM binding, however, was not correlated to the severity of REM atonia loss. CONCLUSION: Decreased nigrostriatal dopaminergic projections may contribute to RBD in MSA.
Asunto(s)
Monoaminas Biogénicas/metabolismo , Cuerpo Estriado/metabolismo , Atrofia de Múltiples Sistemas/fisiopatología , Trastorno de la Conducta del Sueño REM/diagnóstico , Trastorno de la Conducta del Sueño REM/metabolismo , Tetrabenazina/análogos & derivados , Adulto , Distribución por Edad , Anciano , Unión Competitiva , Radioisótopos de Carbono , Cuerpo Estriado/diagnóstico por imagen , Electromiografía , Femenino , Humanos , Radioisótopos de Yodo , Masculino , Persona de Mediana Edad , Atrofia de Múltiples Sistemas/complicaciones , Atrofia de Múltiples Sistemas/metabolismo , Piperidinas , Polisomnografía , Valor Predictivo de las Pruebas , Trastorno de la Conducta del Sueño REM/etiología , Valores de Referencia , Distribución por Sexo , Tetrahidronaftalenos , Tálamo/diagnóstico por imagen , Tálamo/metabolismo , Tomografía Computarizada de Emisión , Tomografía Computarizada de Emisión de Fotón ÚnicoRESUMEN
OBJECTIVE: To explore the neurochemical basis of obstructive sleep apnea (OSA) in multiple-system atrophy (MSA). METHODS: In 13 patients with probable MSA, nocturnal, laboratory-based polysomnography was used to rate the severity of OSA using the apnea-hypopnea index during sleep. SPECT with (-)-5-[123I]iodobenzovesamicol ([123I]IBVM) was utilized to measure the density of thalamic cholinergic terminals, which project from the brainstem pedunculopontine and laterodorsal tegmental nuclei. PET with (+)-[11C]dihydrotetrabenazine ([11C]DTBZ) was also used to measure the density of striatal monoaminergic terminals, which project from the brainstem. Findings in the patient group were compared with data from 12 normal control subjects scanned utilizing [123I]IBVM and 15 normal control subjects utilizing [11C]DTBZ. RESULTS: Age and gender distributions were similar in patient and control groups. The MSA subjects showed decreased [123I]IBVM binding in the thalamus (p < 0.001) and decreased mean [11C]DTBZ binding in the striatum (p < 0.0001) in comparison with the control subjects. In the MSA group, thalamic [123I]IBVM binding was inversely correlated with the severity of OSA (p = 0.011). Striatal [11C]DTBZ binding was not correlated with the severity of OSA (p = 0.19). CONCLUSION: Decreased pontine cholinergic projections may contribute to OSA in MSA.
Asunto(s)
Cuerpo Estriado/metabolismo , Proteínas de Transporte de Membrana , Atrofia de Múltiples Sistemas/fisiopatología , Neuropéptidos , Receptores Colinérgicos/deficiencia , Apnea Obstructiva del Sueño/diagnóstico , Apnea Obstructiva del Sueño/metabolismo , Tetrabenazina/análogos & derivados , Tálamo/metabolismo , Proteínas de Transporte Vesicular , Adulto , Distribución por Edad , Anciano , Unión Competitiva , Proteínas Portadoras/metabolismo , Cuerpo Estriado/diagnóstico por imagen , Femenino , Humanos , Radioisótopos de Yodo , Masculino , Glicoproteínas de Membrana/metabolismo , Persona de Mediana Edad , Atrofia de Múltiples Sistemas/complicaciones , Atrofia de Múltiples Sistemas/diagnóstico por imagen , Proyectos Piloto , Piperidinas , Puente/fisiopatología , Receptores Colinérgicos/metabolismo , Valores de Referencia , Análisis de Regresión , Distribución por Sexo , Apnea Obstructiva del Sueño/etiología , Tetrahidronaftalenos , Tálamo/diagnóstico por imagen , Tomografía Computarizada de Emisión , Tomografía Computarizada de Emisión de Fotón Único , Proteínas de Transporte Vesicular de Acetilcolina , Proteínas de Transporte Vesicular de Aminas BiógenasRESUMEN
As the development of quantised storage media progresses, detailed knowledge is required about the magnetisation reversal behaviour of sub-micron sized magnetic structures in external magnetic fields. Using the Lorentz mode of transmission electron microscopy (LTEM) the magnetic microstructure of thin film samples can be imaged with high spatial resolution. A novel approach for in situ magnetising experiments is described which combines the development of a custom-made sample holder which generates two orthogonal in-plane components of magnetic field in the specimen plane with the benefit of computer-controlled variation of the field. We present a specimen stage suitable for a Philips CM30 Twin/LTEM, which allows the generation of well-defined magnetic in-plane fields in the TEM.
Asunto(s)
Fenómenos Electromagnéticos/instrumentación , Microscopía Electrónica/métodos , Manejo de Especímenes/instrumentación , Campos Electromagnéticos , Diseño de Equipo , Microscopía Electrónica/instrumentación , Diseño de SoftwareRESUMEN
Although neuropsychological symptoms are associated with multiple system atrophy (MSA), sporadic olivopontocerebellar atrophy (sOPCA), and dominantly inherited olivopontocerebellar atrophy (dOPCA), the differences between these groups have not been explored. We compared 28 MSA patients on psychiatric rating scales and neuropsychological measures to 67 sOPCA patients, 42 dOPCA patients, and 30 normal controls. Patients with dOPCA, sOPCA, and MSA all exhibited significant deficits on motor-related tasks, as well as relatively mild deficits in cognitive functioning. Patients with MSA had greater neuropsychological dysfunction, particularly in memory and other "higher order" cognitive processes, than patients with either sOPCA or dOPCA.
Asunto(s)
Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/etiología , Atrofia de Múltiples Sistemas/complicaciones , Atrofias Olivopontocerebelosas/complicaciones , Depresión/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Trastornos Psicomotores/diagnóstico , Trastornos Psicomotores/etiología , Índice de Severidad de la Enfermedad , Trastornos del Habla/diagnóstico , Trastornos del Habla/etiologíaRESUMEN
OBJECTIVE: To determine the percentage of sporadic olivopontocerebellar atrophy (sOPCA) patients who later develop multiple system atrophy (MSA). METHODS: Observations of the course of 51 sOPCA patients 20 years of age or older initially evaluated in an ataxia clinic over 14 years and followed at 3- to 6-month intervals for 3 months to 10 years (median 2.5 years, interquartile range 5 months to 4 years). RESULTS: Seventeen patients evolved to develop MSA, whereas the remaining 34 manifested only progressively worsening cerebellar ataxia. The features of the MSA cases included autonomic failure and parkinsonism in 10 patients, autonomic failure without parkinsonism in six, and parkinsonism without autonomic failure in one. Using survival analysis methods, the authors estimated that 24% of subjects in this population will evolve to MSA within 5 years of the onset of sOPCA symptoms (95% CI 10% to 36%). An older age at onset of symptoms and a shorter time from onset of symptoms to first presentation in a neurology specialty clinic were both highly predictive of evolution to MSA. Six of the 17 patients who evolved to MSA died 4 months to 5 years after they had met diagnostic criteria for MSA. The estimated median survival time from time of transition was 3.5 years. In contrast, death occurred in only one of the 34 patients with sOPCA who did not evolve to MSA. Autopsy examination of all six patients with MSA who died confirmed the diagnosis. CONCLUSIONS: Approximately one-fourth of sporadic olivopontocerebellar atrophy patients will evolve to multiple system atrophy within 5 years, and this transition carries a poor prognosis for survival. Older age at onset of ataxia and earlier presentation in a neurologic specialty clinic predicted transition to MSA.
Asunto(s)
Atrofia de Múltiples Sistemas/diagnóstico , Atrofia de Múltiples Sistemas/etiología , Atrofias Olivopontocerebelosas/complicaciones , Atrofias Olivopontocerebelosas/diagnóstico , Adulto , Factores de Edad , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Atrofia de Múltiples Sistemas/mortalidad , Pronóstico , Modelos de Riesgos Proporcionales , Análisis de Supervivencia , Tasa de SupervivenciaRESUMEN
OBJECTIVE: To evaluate the integrity of neurons containing benzodiazepine receptors in metabolically affected regions of the brain in patients with clinically diagnosed progressive supranuclear palsy (PSP). METHODS: The cerebral distribution of [11C]flumazenil (FMZ), a ligand that binds to the gamma-aminobutyric acid A (GABAA) receptor, and [18F]fluorodeoxyglucose (FDG), a measure of local cerebral glucose metabolism, was determined with PET in 12 patients with PSP and 10 normal control subjects. Tracer kinetic analysis was applied to quantify data and analysis was performed using three-dimensional stereotactic surface projections and stereotactically determined volumes of interest. RESULTS: There was a global reduction in FMZ binding of 13%, with a reduction in the anterior cingulate gyrus of 20% (p = 0.004), where glucose metabolic rates also showed the greatest reduction. CONCLUSIONS: PSP causes loss of benzodiazepine receptors in the cerebral cortex. Consistent with postmortem studies, the authors did not find significant changes in FMZ binding in subcortical nuclei that exhibit the most pathologic change. This study suggests that both loss of intrinsic neurons containing benzodiazepine receptors and deafferentation of the cerebral cortex from distant brain regions contribute to cerebral cortical hypometabolism in PSP.
Asunto(s)
Receptores de GABA-A/fisiología , Parálisis Supranuclear Progresiva/diagnóstico por imagen , Tomografía Computarizada de Emisión , Anciano , Anciano de 80 o más Años , Glucemia/metabolismo , Encéfalo/diagnóstico por imagen , Encéfalo/fisiopatología , Mapeo Encefálico , Femenino , Flumazenil/farmacocinética , Fluorodesoxiglucosa F18 , Moduladores del GABA/farmacocinética , Giro del Cíngulo/diagnóstico por imagen , Giro del Cíngulo/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Valores de Referencia , Parálisis Supranuclear Progresiva/fisiopatologíaRESUMEN
BACKGROUND: In 1994, Oregon implemented the Oregon Health Plan (OHP), extending health care coverage under a system of capitated managed care to uninsured citizens living below the Federal Poverty Level (FPL). We conducted a study to measure receipt of clinical preventive services among women newly enrolled in the OHP. METHODS: Six hundred and sixty six women aged 52-64, and living below the FPL in Oregon were randomly selected from OHP enrollment rosters and interviewed by telephone. A follow-up survey was conducted 1 year later. The main outcome of interest was receipt of a screening mammogram during the first year in the OHP. RESULTS: At enrollment 17% (65/383) of participants had never had health care coverage. Sixty-six percent of the women (220/333) were overdue for a mammogram. Fifty-five percent (121/220) reported cost as the main reason they had not had this procedure. Mammography rates doubled under the OHP (21% to 52%, 95% CI = 0.25-0.38, p < 0.001). Among women who were overdue for a mammogram at the time they enrolled, an expressed plan to get a mammogram (OR3.0, 95% CI = 1.1-8.7, p = 0.04), citing cost as the main reason for being overdue (OR3.0, 95% CI = 1.3-7.2, p = 0.014), receipt of a routine checkup (OR9.5, 95%CI = 3.7-24.9, p < 0.001), and health care provider's (HCP's) recommendation for mammography (OR8.1,95% CI = 2.9-23.0, p < 0.001) were independently associated with receipt of a mammogram. CONCLUSION: The OHP enrolled and successfully delivered clinical preventive services to a medically under served population. Even after removing the financial barrier, obstacles to mammography remain. These may be overcome by health systems changes to insure receipt of routine checkups and appropriate provider recommendations.
Asunto(s)
Reforma de la Atención de Salud , Accesibilidad a los Servicios de Salud , Mamografía/estadística & datos numéricos , Pobreza , Planes Estatales de Salud , Femenino , Estudios de Seguimiento , Humanos , Modelos Logísticos , Programas Controlados de Atención en Salud , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Oregon , Servicios Preventivos de Salud/estadística & datos numéricos , Estados UnidosAsunto(s)
Materiales Dentales/efectos adversos , Hipersensibilidad al Látex , Odontología , Dermatitis Profesional/etiología , Dermatitis Profesional/prevención & control , Guantes Quirúrgicos/efectos adversos , Humanos , Hipersensibilidad al Látex/etiología , Hipersensibilidad al Látex/prevención & control , Exposición ProfesionalRESUMEN
We examined the density of striatal presynaptic monoaminergic terminals, using a ligand for the type 2 vesicular monoamine transporter, (+)-[11C]dihydrotetrabenazine, with positron emission tomography in 7 normal control subjects, 8 multiple system atrophy (MSA) patients with predominantly parkinsonian features (MSA-P), 8 MSA patients with principally cerebellar dysfunction (MSA-C), and 6 sporadic olivopontocerebellar atrophy (sOPCA) patients. The findings were correlated with the results of neurological evaluations and magnetic resonance imaging studies. Specific binding was significantly reduced in the putamen of all patient groups in the order MSA-P < MSA-C < sOPCA, compared with controls. Mean blood-to-brain ligand transport (K1) was significantly decreased in the putamen of all patient groups and in the cerebellar hemispheres of MSA-C and sOPCA but not MSA-P groups, compared with controls. Significant negative correlations were found between striatal binding and the intensity of parkinsonian features and between cerebellar K1 and the intensity of cerebellar dysfunction. The results suggest fundamental differences between MSA-P and MSA-C groups reflecting differential severity of degeneration of nigrostriatal and cerebellar systems in these two forms of MSA. The findings also show that some sOPCA patients have subclinical nigrostriatal dysfunction and are at risk of developing MSA with disease progression.
Asunto(s)
Cuerpo Estriado/diagnóstico por imagen , Atrofia de Múltiples Sistemas/diagnóstico por imagen , Tetrabenazina/análogos & derivados , Adulto , Anciano , Anciano de 80 o más Años , Encéfalo/diagnóstico por imagen , Encéfalo/metabolismo , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Atrofia de Múltiples Sistemas/metabolismo , Tetrabenazina/metabolismo , Tomografía Computarizada de EmisiónRESUMEN
We used (+)[11C]dihydrotetrabenazine, a new ligand for the type 2 vesicular monoamine transporter, with positron emission tomography to study striatal monoaminergic presynaptic terminals in 7 male severe chronic alcoholic subjects without Wernicke-Korsakoff disease compared with 7 male normal controls of similar ages. We found reduced specific binding in the caudate nucleus and putamen in the alcoholic group, and the difference reached significance in the putamen. Specific binding was not decreased in the thalamus, which was examined as a reference structure. We also detected deficits in blood-to-brain transfer rate, K1, in the same regions of the alcoholic group, with a significant difference in the putamen. K1 was unchanged in the thalamus. The finding of reduced striatal VMAT2 in severe chronic alcoholic patients suggests that nigrostriatal monoaminergic terminals are reduced, with or without loss of neurons from the substantia nigra. The findings suggest that the damaging effects of severe chronic alcoholism on the central nervous system are more extensive than previously considered.
Asunto(s)
Alcoholismo/fisiopatología , Cuerpo Estriado/fisiopatología , Glicoproteínas de Membrana/metabolismo , Proteínas de Transporte de Membrana , Terminaciones Nerviosas/fisiopatología , Neuropéptidos , Neurotransmisores/metabolismo , Tetrabenazina/análogos & derivados , Adulto , Anciano , Alcoholismo/metabolismo , Monoaminas Biogénicas/metabolismo , Estudios de Cohortes , Cuerpo Estriado/metabolismo , Humanos , Inyecciones Intravenosas , Masculino , Persona de Mediana Edad , Terminaciones Nerviosas/metabolismo , Fumar/efectos adversos , Tomografía Computarizada de Emisión , Proteínas de Transporte Vesicular de Aminas Biógenas , Proteínas de Transporte Vesicular de MonoaminasRESUMEN
Patients with severe chronic alcoholism have decreased rates of glucose metabolism in the medial frontal lobe and correlated abnormalities of neuropsychological functioning. The potential influence of family history of alcoholism has not been examined in these patients. In a retrospective study, we used neuropsychological tests and neuroimaging employing [18F]fluorodeoxyglucose with positron emission tomography to study 48 older subjects who had histories of severe, chronic alcohol dependence. These patients were divided into two groups: 27 with a first-degree relative with chronic alcoholism and 21 patients without first-degree relative with chronic alcoholism. No differences were found between groups on either neuropsychological or neuroimaging tests. These results suggest that a family history of alcoholism does not moderate the damaging effects of severe chronic alcoholism on the functioning of the medial frontal lobe.
Asunto(s)
Alcoholismo/genética , Glucemia/metabolismo , Lóbulo Frontal/efectos de los fármacos , Pruebas Neuropsicológicas , Tomografía Computarizada de Emisión , Adulto , Anciano , Alcoholismo/diagnóstico por imagen , Alcoholismo/rehabilitación , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/fisiología , Fluorodesoxiglucosa F18/metabolismo , Estudios de Seguimiento , Lóbulo Frontal/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Prolonged excessive consumption of alcohol has been associated with a variety of cognitive disorders accompanied by neuropathological and neurochemical abnormalities of the brain, particularly in the frontal lobes. Studies with positron emission tomography (PET) have shown decreased local cerebral metabolic rates for glucose (lCMRglc) in frontal regions, with correlated abnormalities on neuropsychological tests sensitive to executive functioning. This investigation was designed as a pilot study to examine the effects of abstinence and relapse in patients with severe chronic alcoholism studied longitudinally with PET and with neuropsychological evaluation to assess both general and executive functioning. Six patients, including 4 who remained relatively abstinent and 2 who relapsed following their initial evaluation, were studied twice, with inter-evaluation intervals ranging from 10 to 32 months. The patients who remained abstinent or who had minimal alcohol use showed partial recovery of lCMRglc in two of three divisions of the frontal lobes and improvement on neuropsychological tests of general cognitive and executive functioning, whereas the patients who relapsed had further declines in these areas. These results, although based upon a relatively small number of subjects, provide preliminary support for at least partial recovery of metabolic and cognitive functioning in individual patients who abstain from alcohol.
Asunto(s)
Alcoholismo/metabolismo , Alcoholismo/psicología , Química Encefálica/fisiología , Glucosa/metabolismo , Síndrome de Abstinencia a Sustancias/metabolismo , Síndrome de Abstinencia a Sustancias/psicología , Adulto , Alcoholismo/diagnóstico por imagen , Corteza Cerebral/anatomía & histología , Corteza Cerebral/metabolismo , Enfermedad Crónica , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Pruebas Neuropsicológicas , Recurrencia , Síndrome de Abstinencia a Sustancias/diagnóstico por imagen , Tomografía Computarizada de EmisiónRESUMEN
BACKGROUND: Alcoholic cerebellar degeneration (ACD) is a disorder resulting from severe chronic alcoholism and malnutrition and is characterized by cognitive disturbances, ataxia of gait, and truncal instability, with generally preserved coordination of the upper extremities. OBJECTIVES: To determine whether cognitive deficits in patients with ACD are the same as those seen in patients with severe chronic alcoholism without ACD and to determine whether upper limb motor coordination is different in the 2 groups. DESIGN: We examined cognitive function and upper limb coordination in 56 patients with severe chronic alcoholism, 13 with ACD and 43 without ACD, who had comparable levels of total alcohol intake. Neuropsychological and motor function was measured using an expanded Halstead-Reitan Neuropsychological Test Battery, including the Tactual Performance Test and Grooved Pegboard Test. RESULTS: Neither group had impaired coordination of upper limb function on clinical neurological examination. Both groups had impaired performance on neuropsychological tests involving executive function, but the patients with ACD had greater impairment of upper limb coordination than the patients without ACD as measured by the Tactual Performance Test and Grooved Pegboard Test. CONCLUSIONS: The findings suggest that these 2 groups have similar cognitive deficits but that upper extremity motor functions are more significantly impaired in the ACD group and that quantitative tasks of motor function reveal these impairments.
Asunto(s)
Alcoholismo/fisiopatología , Enfermedades Cerebelosas/fisiopatología , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/fisiopatología , Enfermedades Neuromusculares/fisiopatología , Alcoholismo/complicaciones , Enfermedades Cerebelosas/etiología , Enfermedades Cerebelosas/psicología , Extremidades/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Destreza Motora , Enfermedades Neuromusculares/etiología , Enfermedades Neuromusculares/psicología , Pruebas Neuropsicológicas , Trastornos Nutricionales/complicacionesRESUMEN
Disulfiram is an aldehyde dehydrogenase inhibitor that is widely used as an adjunctive agent in the treatment of patients with severe chronic alcoholism. Recent positron emission tomography (PET) studies of local cerebral metabolic rates for glucose (ICMRglc) and benzodiazepine receptor binding in alcoholic patients have shown regional cerebral abnormalities; however, some of the patients were studied while receiving disulfiram, which could influence the biochemical processes under investigation. In a retrospective investigation, we examined the influence of disulfiram administration on the results of PET studies of ICMRglc and benzodiazepine receptor binding and neuropsychological tests of cognition and executive function in patients with severe chronic alcoholism. [18F]Fluorodeoxyglucose was used to measure ICMRglc in 48 male patients, including 11 receiving and 37 not receiving disulfiram in therapeutic doses. [11C]Flumazenil was used to measure benzodiazepine receptor binding in 17 male patients, including 3 receiving and 14 not receiving disulfiram. All patients studied with FMZ were also examined with fluorodeoxyglucose. PET studies of ICMRglc revealed significantly decreased global values in the patients receiving disulfiram compared with those not receiving disulfiram. PET studies of benzodiazepine receptor binding revealed decreased flumazenil influx and distribution volume in patients receiving disulfiram. The neuropsychological tests demonstrated no differences between the two groups of subjects. The findings suggest that disulfiram may influence the results of PET studies of glucose metabolism and benzodiazepine receptor binding.
Asunto(s)
Disuasivos de Alcohol/efectos adversos , Alcoholismo/diagnóstico por imagen , Glucemia/metabolismo , Encéfalo/efectos de los fármacos , Disulfiram/efectos adversos , Metabolismo Energético/efectos de los fármacos , Pruebas Neuropsicológicas , Tomografía Computarizada de Emisión , Adulto , Anciano , Disuasivos de Alcohol/uso terapéutico , Alcoholismo/rehabilitación , Encéfalo/diagnóstico por imagen , Desoxiglucosa/análogos & derivados , Desoxiglucosa/metabolismo , Disulfiram/uso terapéutico , Flumazenil/farmacocinética , Fluorodesoxiglucosa F18 , Humanos , Masculino , Persona de Mediana Edad , Receptores de GABA-A/efectos de los fármacosRESUMEN
The importance of test kits is increasing due to economical reasons. The different types of test kits allow qualitative, semiquantitative or quantitative results depending on the requirements. For applications where rapidity and mobility are absolutely necessary, they have advantages compared to laboratory methods. This is demonstrated by two typical examples. Besides the advantages, the limits of test kits are also mentioned. Test kits look very simple and are really easy to handle; nevertheless, not only the producers but also the users have to fulfil some basic demands.
RESUMEN
In January 1988, Oregon became the first state to require hospital-based reporting of attempted suicide (AS) in all adolescents less than 18 years old. From January to December 1988, 644 cases of AS were reported (annual rate of 214 per 100,000 population, ages 10 to 17 years). We compared these 644 cases of AS with all 137 Oregon adolescents less than 18 years old who committed suicide in Oregon during the 10-year-period 1979 through 1988, and found that the strongest predictor of outcome was method used.